Back to LTRN

UBS Group AG → LTRN

UBS Group AG LTRN Position History

Lantern Pharma Inc. • Healthcare

Quarters held
12
Latest value
$120K
Q3 2026
Peak value
$120K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$107K
Q3 2025$34K
Q3 2025$3K
Q4 2025$20K
Q4 2025$6K
Q4 2025$7K
Q1 2026$9K
Q1 2026$5K
Q2 2026$27K
Q2 2026$42K
Q3 2026$7K
Q3 2026$120K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$120K118.9K——
Q3 2026$7K6.5K——
Q2 2026$42K10.1K——
Q2 2026$27K6.5K——
Q1 2026$5K3.6K——
Q1 2026$9K6.5K——
Q4 2025$7K2.3K——
Q4 2025$6K1.8K——
Q4 2025$20K6.5K——
Q3 2025$3K749——
Q3 2025$34K7.9K——
Q3 2025$107K24.5K——

Other funds holding LTRN

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B